ARTICLE | Company News
Arch Biopartners, University of Colorado deal
December 13, 2010 8:00 AM UTC
Arch received an exclusive, worldwide license for the university's pending patent in the area of peptides and solid surfaces for $36,000 up front. Arch will issue 150,000 of its common shares to the u...